Nationwide Fund Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-23,692
| Closed | -$602K | – | 1652 |
|
|
2017
Q3 | $602K | Sell |
23,692
-1,074
| -4% | -$27.3K | ﹤0.01% | 2086 |
|
|
2017
Q2 | $676K | Buy |
24,766
+4,136
| +20% | +$113K | ﹤0.01% | 2017 |
|
|
2017
Q1 | $683K | Sell |
20,630
-12,198
| -37% | -$404K | ﹤0.01% | 1985 |
|
|
2016
Q4 | $781K | Sell |
32,828
-790
| -2% | -$18.8K | ﹤0.01% | 1918 |
|
|
2016
Q3 | $1.23M | Buy |
33,618
+4,630
| +16% | +$170K | 0.01% | 1644 |
|
|
2016
Q2 | $646K | Buy |
28,988
+13,090
| +82% | +$292K | ﹤0.01% | 2003 |
|
|
2016
Q1 | $331K | Hold |
15,898
| – | – | ﹤0.01% | 2296 |
|
|
2015
Q4 | $482K | Buy |
15,898
+10,098
| +174% | +$306K | ﹤0.01% | 2134 |
|
|
2015
Q3 | $143K | Sell |
5,800
-17,888
| -76% | -$441K | ﹤0.01% | 2736 |
|
|
2015
Q2 | $760K | Sell |
23,688
-503
| -2% | -$16.1K | ﹤0.01% | 2023 |
|
|
2015
Q1 | $864K | Buy |
24,191
+7,912
| +49% | +$283K | ﹤0.01% | 1959 |
|
|
2014
Q4 | $370K | Buy |
16,279
+927
| +6% | +$21.1K | ﹤0.01% | 2352 |
|
|
2014
Q3 | $298K | Hold |
15,352
| – | – | ﹤0.01% | 2502 |
|
|
2014
Q2 | $557K | Buy |
15,352
+8,656
| +129% | +$314K | ﹤0.01% | 2203 |
|
|
2014
Q1 | $260K | Sell |
6,696
-115
| -2% | -$4.47K | ﹤0.01% | 2369 |
|
|
2013
Q4 | $194K | Sell |
6,811
-114
| -2% | -$3.25K | ﹤0.01% | 2700 |
|
|
2013
Q3 | $248K | Sell |
6,925
-5,024
| -42% | -$180K | ﹤0.01% | 2558 |
|
|
2013
Q2 | $399K | Buy |
+11,949
| New | +$399K | ﹤0.01% | 2123 |
|